Trial Profile
Clinical Study to Assess the Positive Predictive Value of NPC-07 Induced Tissue Fluorescence in Patients With Malignant Glioma (WHO Grades III/IV)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2014
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioma
- Focus Diagnostic use
- Sponsors Nobelpharma
- 25 Nov 2014 New trial record